pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,879 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 29 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Infectious Disease3

    Date TBD

    50
    ›RECRUITINGphase readoutNCT05366361: The Dynamics of Human Atrial Fibrillation

    Sponsor: Stanford University. Phase: . Conditions: Atrial Fibrillation, Arrhythmias, Cardiac

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07414797: Discomfort Following Oral Biopsy Comparing Laser and Punch Biopsy

    Sponsor: Catholic University of the Sacred Heart. Phase: NA. Conditions: Oral Lichen Planus, Biopsy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06126497: Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients

    Sponsor: Suven Life Sciences Limited. Phase: PHASE2. Conditions: Major Depressive Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07505810: Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months

    Sponsor: Sinovac Biotech Co., Ltd. Phase: PHASE3. Conditions: Epidemic Meningitis, Meningococcal Vaccines

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07276360: Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda

    Sponsor: Uganda Cancer Institute. Phase: PHASE2. Conditions: Cervical Cancer, Cervix Cancer, Cervical Adenocarcinoma, Cervical Small Cell Carcinoma, Cervical Adenosquamous Carcinoma

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT05512260: Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs

    Sponsor: Karolinska Institutet. Phase: NA. Conditions: Neoplasm, Colorectal, Neoplasm, Breast, Neoplasm, Ovarian

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05341960: Nourishing Beginnings: Addressing Food Insecurity During Pregnancy

    Sponsor: Case Western Reserve University. Phase: NA. Conditions: Pregnancy Related, Food Insecurity, Premature Birth, Pregnancy Complications

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07520682: Orthognathic Surgery in Anterior Open Bite: a Retrospective Study of 50 Patients With Initial Tongue Malposition

    Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Patients With Anterior Open Bite Malocclusion and Who Benefited of an Orthognathic Surgery, Infantile Swallowing and Tongue Malposition Necessitating Tongue Rehabilitation

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04438382: Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

    Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE2. Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Steroid-Refractory Pneumonitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07111559: Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial

    Sponsor: Nippon Medical School. Phase: PHASE4. Conditions: Lacunar Stroke, Stroke, Ischemic Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07306559: A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

    Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Advanced Relapsed or Refractory Germ Cell Tumours, Advanced Relapsed or Refractory Endometrial Cancer, Advanced Relapsed or Refractory Ovarian Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07458659: Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

    Sponsor: Chulalongkorn University. Phase: EARLY_PHASE1. Conditions: Relapsed/Refractory Multiple Myeloma (MM)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07265479: A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

    Sponsor: Organon and Co. Phase: PHASE3. Conditions: Atopic Dermatitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06161662: STimulation Electronically of Acupoints for Postoperative Delirium in elderlY Patients

    Sponsor: Zhihong LU. Phase: NA. Conditions: Anesthesia, Postoperative Delirium, Electroencephalogram

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06014762: P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

    Sponsor: Poseida Therapeutics, Inc.. Phase: PHASE1. Conditions: Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, High-grade B-cell Lymphoma, Primary Mediastinal Large B-cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (tFL), Follicular Lymphoma Grade 3B, DLBCL, DLBCL - Diffuse Large B Cell Lymphoma, DLBCL Arising From Follicular Lymphoma, DLBCL, Diffused Large B Cell Lymphoma, DLBCL NOS

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT03065062: Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors

    Sponsor: Dana-Farber Cancer Institute. Phase: PHASE1. Conditions: Lung Cancer Squamous Cell, Solid Tumors, Head & Neck Cancer, Pancreatic Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06414603: A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy

    Sponsor: Natera, Inc.. Phase: NA. Conditions: Heart Transplant Failure and Rejection

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05206227: Histamine as a Molecular Transducer of Adaptation to Exercise

    Sponsor: University of Oregon. Phase: EARLY_PHASE1. Conditions: Postexercise Hypotension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07314073: [18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer

    Sponsor: Asan Medical Center. Phase: PHASE2. Conditions: Stage III Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05229341: Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules

    Sponsor: City of Hope Medical Center. Phase: NA. Conditions: Thyroid Gland Carcinoma

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06871683: ClotTriever® Thrombectomy System Use-Result Survey in Japan

    Sponsor: Inari Medical. Phase: . Conditions: Deep Vein Thrombosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT00378105: Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma

    Sponsor: Dana-Farber Cancer Institute. Phase: PHASE1. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03308305: Cracking Coma: Towards EEG and MRI Based Precision Medicine After Cardiac Arrest

    Sponsor: Rijnstate Hospital. Phase: . Conditions: Post-Anoxic Coma, Postanoxic Enchephalopathie

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06594094: An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE)

    Sponsor: HuidaGene Therapeutics Co., Ltd.. Phase: EARLY_PHASE1. Conditions: Duchenne Muscular Dystrophin (DMD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07492966: Exosomes Effect on Visual Function in CVI

    Sponsor: Hatice Semrin Timlioglu İper. Phase: . Conditions: Cortical Visual Impairment, Visual Function

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06901466: STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant

    Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital. Phase: PHASE4. Conditions: Mitral Regurgitation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07323966: Feasibility of Mask-Free Radiotherapy for Brain Tumor Patients

    Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Phase: NA. Conditions: Brain Tumor

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05728866: Effectiveness of IVR Combined With Task-Specific Training on Hemiplegic Arm Function Following Stroke

    Sponsor: Virginia Commonwealth University. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02649166: Responsive Deep Brain Stimulator for Essential Tremor

    Sponsor: University of Florida. Phase: NA. Conditions: Essential Tremor

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03540485: Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis

    Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla. Phase: PHASE1. Conditions: Sclerosis, Multiple, Autoimmune Diseases of the Nervous System, Nervous System Diseases, Autoimmune Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07545785: Electroacupuncture and Cupping for Shoulder Tendinitis

    Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City. Phase: NA. Conditions: Shoulder Tendinopathy, Shoulder Tendinitis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT00588315: In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Skin Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06470308: Prescribing Outcomes of a GP-Targeted Deprescribing Educational Intervention: A Cluster Randomized Trial

    Sponsor: University of Crete. Phase: NA. Conditions: Medication Overuse, Deprescriptions, Polypharmacy, Frailty Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06712108: Double Unit Cord Blood Transplant in Hematologic Malignancies.

    Sponsor: Seoul National University Hospital. Phase: . Conditions: Adult Double Unit Cord Blood Transplant

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07394608: Paired Non-invasive VNS in Adolescent Cerebral Palsy Rehabilitation

    Sponsor: Icahn School of Medicine at Mount Sinai. Phase: NA. Conditions: Cerebral Palsy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04531917: The Effect of Pain Neuroscience Education and Behavioural Graded Activity on Chronic Pain in Breast Cancer Survivors

    Sponsor: Universitair Ziekenhuis Brussel. Phase: NA. Conditions: Breast Neoplasms, Survivors, Chronic Pain

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05731817: Profile of COVID-19 Patients Related to Fatigue

    Sponsor: Universidad de Granada. Phase: . Conditions: COVID-19

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07335640: Impact of an Information Sheet Given to Parents After an Initial Consultation for a Simple Febrile Seizure at Strasbourg University Hospital

    Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Febrile Crisis

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT04987840: A Multi-Center Diagnostic Stewardship Program to Improve Respiratory Culture Utilization in Critically Ill Children

    Sponsor: Johns Hopkins University. Phase: . Conditions: Ventilator Associated Pneumonia, Tracheobronchitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06724289: Psilocybin for Prolonged Grief Disorder

    Sponsor: University of Virginia. Phase: EARLY_PHASE1. Conditions: Prolonged Grief Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04891289: Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Intrahepatic Cholangiocarcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07433868: Evaluation of Implant Stability Following Maxillary Sinus Floor Elevation Through Piezoelectric Trans-crestal Approach Versus Crestal Implant Approach

    Sponsor: International Dental Contiuing Education. Phase: NA. Conditions: Internal Sinus Lifting

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07504068: Effects of Physical Exercise and a Nutritional Supplement on Body Composition, Metabolic Function, and Overall Health in Adults With a Metabolically Challenging Profile

    Sponsor: University of Valencia. Phase: NA. Conditions: Aging, Adults With Overweight and Obesity, Supplementation, Exercise

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06802068: Change in Omega 3 Index in Healthy Adults With OmeGo or a Standard Omega-3 Oil Supplement

    Sponsor: Hofseth Biocare ASA. Phase: NA. Conditions: Supplementation in Healthy Adults to Assess Impact on Omega 3 Index and Cardiometabolic Health

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05546268: Study of Oral MRT-2359 in Selected Cancer Patients

    Sponsor: Monte Rosa Therapeutics, Inc. Phase: PHASE1. Conditions: NSCLC, SCLC, High Grade Neuroendocrine Cancer, DLBCL, L-MYC and N-MYC Amplified Solid Tumors, NSCLC With High or Low L-MYC or N-MYC Expression, HR-positive, HER2-negative Breast Cancer, Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07536568: Sublingual Caffeine on Reducing Recovery Time and Postoperative Agitation in Elderly Patients Undergoing General Anesthesia

    Sponsor: Cairo University. Phase: NA. Conditions: Sublingual, Caffeine, Recovery Time, Postoperative Agitation, Elderly Patients, General Anesthesia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07247968: Subanesthetic Esketamine in Modified ECT for Severe Depression in Adolescents: Clinical and Mechanistic Study

    Sponsor: Min Su. Phase: EARLY_PHASE1. Conditions: Esketamine, ECT, Depression, Adolescent

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07355868: Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy

    Sponsor: Regend Therapeutics. Phase: EARLY_PHASE1. Conditions: Chronic Obstructive Pulmonary Disease (COPD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06503991: Acute Coronary Syndrome KCMC_1

    Sponsor: Duke University. Phase: NA. Conditions: Hypertension, HIV

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02490891: Study of the Angiogenesis by PET/CT in Patients With Lymphoma

    Sponsor: Centre Henri Becquerel. Phase: PHASE2. Conditions: Lymphoma

    full page →ctgov ↗
    ← prev
    page 15 of 98
    next →